+Compare
MYGN
Stock ticker:
NASDAQ
AS OF
Jul 1 closing price
Price
$18.63
Change
+$0.46 (+2.53%)
Capitalization
1.5B

MYGN Price Prediction, Myriad Genetics AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

Momentum Indicator for MYGN turns positive, indicating new upward trend

MYGN saw its Momentum Indicator move above the 0 level on June 23, 2022. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In 76 of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MYGN's RSI Indicator exited the oversold zone, of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MYGN just turned positive on June 23, 2022. Looking at past instances where MYGN's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MYGN advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

MYGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where MYGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

MYGN moved below its 50-day moving average on May 31, 2022 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MYGN entered a downward trend on June 28, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MYGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.575) is normal, around the industry mean (6.877). P/E Ratio (0.000) is within average values for comparable stocks, (92.096). Projected Growth (PEG Ratio) (0.318) is also within normal values, averaging (4.201). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (2.157) is also within normal values, averaging (79.304).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

MYGN is expected to report earnings to fall 196.00% to 2 cents per share on August 02

Myriad Genetics MYGN Stock Earnings Reports
Q2'22
Est.
$0.03
Q1'22
Beat
by $0.05
Q4'21
Est.
$-0.02
Q3'21
Beat
by $0.01
Q2'21
Beat
by $0.21
The last earnings report on May 05 showed earnings per share of -2 cents, beating the estimate of -8 cents. With 439.91K shares outstanding, the current market capitalization sits at 1.50B.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 5.73B. The market cap for tickers in the group ranges from 775 to 3.72T. MKYSF holds the highest valuation in this group at 3.72T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -26%. HTGM experienced the highest price growth at 98%, while ABMT experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -68%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 71
SMR Rating: 67
Profit Risk Rating: 83
Seasonality Score: -3 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a developer of therapeutic and predictive medicine products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
320 Wakara Way
Phone
+1 801 584-3600
Employees
2400
Web
https://www.myriad.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MJRFX20.890.24
+1.16%
BlackRock Mid-Cap Value K
TRPIX41.180.47
+1.15%
T. Rowe Price Value I
JASOX23.500.22
+0.95%
JHancock New Opportunities A
BGITX10.840.04
+0.36%
Baillie Gifford International Alpha 2
EILIX11.250.02
+0.18%
Eaton Vance International Small-Cap I

MYGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with PSNL. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then PSNL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYGN
1D Price
Change %
MYGN100%
+2.53%
PSNL - MYGN
63%
Loosely correlated
-1.45%
PACB - MYGN
59%
Loosely correlated
+1.13%
DMTK - MYGN
59%
Loosely correlated
-0.36%
TWST - MYGN
59%
Loosely correlated
+6.06%
EXAS - MYGN
58%
Loosely correlated
+4.42%
More